Retailers and High Value Network Individuals (HNIs) would be in the wrong if Gland Pharma’s initial public offering (IPO) promoted by Fosun in China was lost. Shares of the Hyderabad-based company have gained 40 percent over its IPO price of 1,500 rupees. On Monday, the shares rose 15 percent to …
Read More »
Gland Pharma made a firm debut in the equity markets on Friday. The action was listed in ₹1710, a premium of 14% on its issue price of ₹1500 each. Gland Pharma’s initial public offering (IPO) was open for subscription on November 9-11, with a price band of ₹1,490-1,500 per share. …
Read More »
Gland Pharma shares made a strong debut on the BSE and NSE today. His shares went up as much as ₹1,819 in EEB compared to the issue price of ₹1,500. The pharmaceutical company’s initial public offering (IPO), which closed on November 11, was signed twice. Of the company ₹The initial …
Read More »
Gland Pharma’s initial public offering was fully subscribed on the last day of subscription today. The numbers were subscribed 1.03 times as of 1:45 pm today. Gland Pharma’s IPO, the largest IPO of a pharmaceutical company in India, comprises a new issue of shares worth up to ₹1,250 crore and …
Read More »